Cargando…

Pharmacology of Modulators of Alternative Splicing

More than 95% of genes in the human genome are alternatively spliced to form multiple transcripts, often encoding proteins with differing or opposing function. The control of alternative splicing is now being elucidated, and with this comes the opportunity to develop modulators of alternative splici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bates, David O., Morris, Jonathan C., Oltean, Sebastian, Donaldson, Lucy F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Pharmacology and Experimental Therapeutics 2017
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226212/ https://www.ncbi.nlm.nih.gov/pubmed/28034912 http://dx.doi.org/10.1124/pr.115.011239

Ejemplares similares

Alternative Splicing in Angiogenesis
por: Bowler, Elizabeth, et al.
Publicado: (2019)

Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease
por: Stevens, Megan, et al.
Publicado: (2018)

Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis
por: Stevens, Megan, et al.
Publicado: (2019)

Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing
por: Stevens, Megan, et al.
Publicado: (2019)

Regulation of Epithelial-Mesenchymal Transitions by Alternative Splicing: Potential New Area for Cancer Therapeutics
por: Li, Ling, et al.
Publicado: (2023)

Alternative RNA splicing: contribution to pain and potential therapeutic strategy
por: Donaldson, Lucy F., et al.
Publicado: (2016)

The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain
por: Hulse, Richard P., et al.
Publicado: (2016)

SRPK1 inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing
por: Mavrou, Athina, et al.
Publicado: (2016)

A drug-repositioning screen using splicing-sensitive fluorescent reporters identifies novel modulators of VEGF-A splicing with anti-angiogenic properties
por: Star, Eleanor, et al.
Publicado: (2021)

Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo
por: Oltean, Sebastian, et al.
Publicado: (2008)

Alternative splicing modulation by G-quadruplexes
por: Georgakopoulos-Soares, Ilias, et al.
Publicado: (2022)

Histone Marks-Dependent Effect on Alternative Splicing: New Perspectives for Targeted Splicing Modulation in Cancer?
por: Imbriano, Carol, et al.
Publicado: (2022)

Histone Deacetylase Activity Modulates Alternative Splicing
por: Hnilicová, Jarmila, et al.
Publicado: (2011)

Mechanisms of non-coding RNA-modulated alternative splicing in cancer
por: Wang, Xiaolin, et al.
Publicado: (2022)

Splicing and alternative splicing in rice and humans
por: E, Zhiguo, et al.
Publicado: (2013)

Alternative splicing in cardiomyopathy
por: Beqqali, A.
Publicado: (2018)

Alternative splicing: the pledge, the turn, and the prestige: The key role of alternative splicing in human biological systems
por: Gallego-Paez, L. M., et al.
Publicado: (2017)

The functional modulation of epigenetic regulators by alternative splicing
por: Lois, Sergio, et al.
Publicado: (2007)

Alternative RNA splicing in tumour heterogeneity, plasticity and therapy
por: Öther-Gee Pohl, Sebastian, et al.
Publicado: (2022)

The VEGF-A exon 8 splicing-sensitive fluorescent reporter mouse is a novel tool to assess the effects of splicing regulatory compounds in vivo
por: Stevens, M., et al.
Publicado: (2019)

Alternative Splicing Events and Their Clinical Significance in Colorectal Cancer: Targeted Therapeutic Opportunities
por: Manabile, Mosebo Armstrong, et al.
Publicado: (2023)

Roles of alternative splicing in modulating transcriptional regulation
por: Li, Jin, et al.
Publicado: (2017)

Alternative Splicing in Plant Immunity
por: Yang, Shengming, et al.
Publicado: (2014)

Alternative Splicing in Hepatocellular Carcinoma
por: Lee, Seung Eun, et al.
Publicado: (2020)

Alternative Splicing in Myeloid Malignancies
por: Gurnari, Carmelo, et al.
Publicado: (2021)

VEGF‐A(165)b protects against proteinuria in a mouse model with progressive depletion of all endogenous VEGF‐A splice isoforms from the kidney
por: Stevens, Megan, et al.
Publicado: (2017)

Regulation of alternative splicing and polyadenylation in neurons
por: Lee, Seungjae, et al.
Publicado: (2023)

Isoforms of Base Excision Repair Enzymes Produced by Alternative Splicing
por: Boldinova, Elizaveta O., et al.
Publicado: (2019)

Alternative Splice in Alternative Lice
por: Tovar-Corona, Jaime M., et al.
Publicado: (2015)

Modulation of insulin secretion by RBFOX2-mediated alternative splicing
por: Moss, Nicole D., et al.
Publicado: (2023)

Identification of Common Genetic Variation That Modulates Alternative Splicing
por: Hull, Jeremy, et al.
Publicado: (2007)

In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin
por: Laustriat, Delphine, et al.
Publicado: (2015)

Alternative splicing and the progesterone receptor in breast cancer
por: Cork, David MW, et al.
Publicado: (2008)

Diversification of the muscle proteome through alternative splicing
por: Nakka, Kiran, et al.
Publicado: (2018)

Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia()
por: Hulse, R.P., et al.
Publicado: (2014)

Alternative splicing of TIA‐1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance
por: Hamdollah Zadeh, Maryam A., et al.
Publicado: (2014)

Alcoholism and Alternative Splicing of Candidate Genes
por: Sasabe, Toshikazu, et al.
Publicado: (2010)

Alternative splicing in plants – coming of age
por: Syed, Naeem H., et al.
Publicado: (2012)

Aberrant alternative splicing in breast cancer
por: Yang, Quan, et al.
Publicado: (2019)

Alternative Splicing in Cancer and Immune Cells
por: Bernard, Antoine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ulu3skgrsevhu6lhmg2n78ee84